Thus, the anti-proliferative activity of SecinH3 in EGFR-TKI resistant NSCLC cells may be explained by its dual inhibitory effect on both, EGFR and IGF1R signaling, which may prevent the cells from circumventing EGFR inhibition by increased IGF1R signaling. Here, IGF1R is linked to non-small cell lung carcinoma.